IL22 and primary cutaneous T-cell non-Hodgkin lymphoma: They revealed that miR-150 inhibited the metastasis of CTCL cells by suppressing IL-22 activation, which in turn inhibited sustained interaction of CCL20-CCR6 in CTCL cells [40].